NS-3623
CAS No. 343630-41-1
NS-3623( NS 3623 | NS3623 )
Catalog No. M14170 CAS No. 343630-41-1
A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | Get Quote |
|
| 10MG | 115 | Get Quote |
|
| 25MG | 237 | Get Quote |
|
| 50MG | 385 | Get Quote |
|
| 100MG | 575 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNS-3623
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
-
DescriptionA novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation); inhibits RBC g(Cl) after oral administration to normal mice (ED50= 25 mg/kg), ameliorates erythrocyte dehydration in transgenic SAD mice; increases the macroscopic current conducted by the hERG channels by increasing the time constant for channel inactivation; affects native I(Kr), decreases QT variability and distinctly decreases the occurrence of extrasystoles in the acutely bradypaced hearts.Anemia Discontinued.
-
In Vitro——
-
In VivoAnimal Model:Anesthetized guinea pigDosage:30 mg/kg Administration:Intravenous injection; lasting for 3 minutes Result:Shortened the corrected QT interval by 25 +/- 4%.
-
SynonymsNS 3623 | NS3623
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaOther Indications
-
IndicationAnemia
Chemical Information
-
CAS Number343630-41-1
-
Formula Weight427.185
-
Molecular FormulaC15H10BrF3N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (585.23 mM)
-
SMILESO=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=CC=C(Br)C=C2C3=NNN=N3
-
Chemical NameN-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bennekou P, et al. Blood. 2001 Mar 1;97(5):1451-7.
2. Hansen RS, et al. Mol Pharmacol. 2006 Oct;70(4):1319-29.
3. Hansen RS, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):996-1002.
4. Hansen RS, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41.
molnova catalog
related products
-
Azimilide dihydrochl...
A class ΙΙΙ antiarrhythmic agent that blocks hERG channel; blocks HERG channel at 0.1 and 1 Hz with IC50s of 1.4 uM and 5.2 uM respectively.
-
VU591 hydrochloride
VU591 hydrochloride is a selective renal outer medullary potassium channel (Kir1.1, ROMK) antagonist (IC50:0.24 μM).?Thought to block the intracellular pore of the Kir1.1 channel.?Exhibits no effect on Kir7.1 at concentrations up to 10 μM;?does not inhibit Kir2.1, Kir2.3 or Kir4.1.?
-
Senicapoc
A potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM).
Cart
sales@molnova.com